OROPHARYNGEAL CANCER STAGE UNSPECIFIED

OROPHARYNGEAL CANCER STAGE UNSPECIFIED was reported 37 times

These drug classes are most commonly taken by patients reporting OROPHARYNGEAL CANCER STAGE UNSPECIFIED:

# Drug Count
0 Tumor Necrosis Factor Blocker [EPC] 10
1 Folate Analog Metabolic Inhibitor [EPC] 5
2 Platinum-based Drug [EPC] 4
3 Benzodiazepine [EPC] 3
4 Loop Diuretic [EPC] 3
5 Proton Pump Inhibitor [EPC] 3
6 Atypical Antipsychotic [EPC] 2
7 Corticosteroid [EPC] 2
8 Epidermal Growth Factor Receptor Antagonist [EPC] 2
9 Nonsteroidal Anti-inflammatory Drug [EPC] 2
10 Platelet Aggregation Inhibitor [EPC] 2
11 Thiazide Diuretic [EPC] 2
12 Aminoglycoside Antibacterial [EPC] 1
13 Angiotensin 2 Receptor Blocker [EPC] 1
14 Anti-epileptic Agent [EPC] 1
15 Azole Antifungal [EPC] 1
16 Blood Viscosity Reducer [EPC] 1
17 CD20-directed Cytolytic Antibody [EPC] 1
18 Calcineurin Inhibitor Immunosuppressant [EPC] 1
19 Estrogen [EPC] 1
20 HMG-CoA Reductase Inhibitor [EPC] 1
21 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
22 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
23 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
24 Microtubule Inhibitor [EPC] 1
25 Mood Stabilizer [EPC] 1
26 Nucleoside Metabolic Inhibitor [EPC] 1
27 Opioid Agonist [EPC] 1
28 Osmotic Laxative [EPC] 1
29 P2Y12 Platelet Inhibitor [EPC] 1
30 Parathyroid Hormone Analog [EPC] 1
31 Phosphodiesterase 5 Inhibitor [EPC] 1
32 Potassium Salt [EPC] 1
33 Sympathomimetic-like Agent [EPC] 1
34 Tetracycline-class Drug [EPC] 1
35 Vasopressin V2 Receptor Antagonist [EPC] 1
36 Vitamin B12 [EPC] 1
37 Vitamin C [EPC] 1
38 Vitamin D [EPC] 1